PRP (platelet-rich plasma)

Treatment with platelet-rich plasma, also known as platelet derived growth factors, consists of the infiltration of plasma with an abundant concentration of platelets obtained by centrifuging a sample of the patient's own blood. When activated, the platelets release growth factors and other substances involved in tissue regeneration mechanisms. The aim of this type of treatment is to promote, stimulate or initiate the process of regeneration and healing of damaged tissue. 
For this purpose, the patient's blood is extracted at the time of treatment and centrifuged to separate the different components of the blood, obtaining different products for different indications. 
The main indications are the following: 
- Tendinopathies and chronic enteropathies.
- Chondropathies and mild chondral injuries and degenerative joint diseases.
- Chronic ligament injuries
- Some fractures accelerating the process of bone consolidation.
- Chronic fasciitis
- Muscle injuries (partial fibrillar rupture).
It is important to bear in mind that before resorting to PRP treatment it is necessary to have previously undergone conservative treatment, including rest, adequate analgesic and anti-inflammatory treatment and targeted physiotherapy, and in the absence of improvement with the usual procedures, biological treatment, which should always be accompanied by good treatment with a physiotherapist.
Although there is already experience on the safety and benefits of this type of therapy, research is still ongoing to learn more about its mechanism of action.



Monocytes is a system developed from the most advanced technology that allows minimally manipulated autologous monocytes to be obtained in a single step, separating them from the rest of the blood components. 


This procedure does not include any traumatic mechanical action (centrifugation) or enzymatic treatments.  



Our immune system plays a critical role in development, homeostasis and tissue repair. 


Monocytes and macrophages are among the first blood cells to respond to tissue damage. 


Anti-inflammatory monocytes (AM) have a pro-regenerative activity that positively influences matrix remodelling, angiogenesis and anti-fibrotic processes.  


M2 macrophages, in addition to phagocytic activity, promote new matrix formation and wound healing by releasing various factors.


They are indispensable in the process of tissue regeneration, through the release of substances that interact in the microenvironment of tissue damage and are also involved in processes of vascular remodelling, muscle-tendon remodelling, bone regeneration and synovial homeostasis.

Documento Adobe Acrobat 4.3 MB